{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-196481","form_type":"8-K","ticker":"VNDA","cik":"0001347178","company_name":"Vanda Pharmaceuticals Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.744175+00:00","generated_at":"2026-05-31T10:45:03.543379+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vanda amends Rights Agreement to clarify definitions of Acting in Concert and Beneficial Owner","bullets":["Entered Amendment No. 2 to Rights Agreement on August 7, 2024 with Equiniti Trust Company as rights agent.","Amendment makes punctuation corrections to the definition of 'Acquiring Person'.","Amends and restates definitions of 'Acting in Concert' and 'Beneficial Owner' for clarifying changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-196481","json":"https://secwatch.observer/filing/0001193125-24-196481.json","markdown":"https://secwatch.observer/filing/0001193125-24-196481.md","text":"https://secwatch.observer/filing/0001193125-24-196481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347178/000119312524196481/0001193125-24-196481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347178/000119312524196481/d862724d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:45:03.543379+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}